Anzeige
Mehr »
Login
Sonntag, 29.01.2023 Börsentäglich über 12.000 News von 679 internationalen Medien
Breaking News! Beeindruckende Zahlen bei Cybeats Technologies!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Endpoints News

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
19.01.Amarin, Sarissa continue playing out activist attack
19.01.Off Editas' shelves, iNK cell therapies float to Shoreline
19.01.After hashing out comeback plans, Deciphera looks to raise $125M from stock sale
19.01.By summer solstice, we'll know the fate of Intercept's NASH drug
19.01.Horizon claims mid-stage victory in rare disease, lines up PhIII for new owners at Amgen
19.01.Ipsen has go/no-go decision to make after biotech partner's Parkinson's drug flunks PhIIb
19.01.Don't pack your sunglasses: No plans to move JP Morgan conference, bank says
18.01.Merck discovers 'root cause' of nitrosamine levels in blockbuster diabetes drugs
18.01.Sun Pharma picks 'Dr. Pimple Popper' for educational acne campaign
18.01.Amgen targets physicians with biosimilars education campaign in advance of expected 2023 breakout
18.01.FDA slaps Optum Infusion with a warning letter over 'insanitary' production conditions
18.01.Bristol Myers debuts first Opdualag campaign, adds to its two-combo cancer drug marketing
18.01.Drugmakers seek tweaks to FDA guidance on measuring development in pediatric trials
18.01.FDA+ roundup: Lessons learned from two quality ratings pilots; Expanded FDA collab with organ-on-a-chip company
18.01.FDA urges federal judge to protect abortion pill access
18.01.Amgen extends autoimmune pact with small Michigan biotech
18.01.Pathalys inks development deal with Abingworth company, raising $150M
18.01.Bluebird hopes to raise upwards of $100M by selling shares
18.01.J&J reports second HIV vaccine regimen failure in 18 months
18.01.Ex-US Commerce Secretary Wilbur Ross pairs his SPAC with Alzheimer's biotech
18.01.With CEO search, PhIII study underway, Fulcrum Therapeutics raises $125M from stock offering
18.01.Bankrupt PhaseBio settles with investor-partner, handing off late-stage drug
18.01.Gene therapy side effects prompt search for new delivery methods
18.01.Ready to expand, GenScript raises $224M for CDMO focused on antibodies, cell and gene therapies
17.01.Akili cuts about 30% of staff in effort to be 'extremely lean'